# SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome

> **NCT06774534** · — · RECRUITING · sponsor: **University of Padova** · enrollment: 40 (estimated)

## Conditions studied

- Respiratory Distress Syndrome (RDS)
- Respiratory Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06774534
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-28
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06774534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06774534, "SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06774534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*